Postmarketing safety surveillance of sofpironium gel, 12.45%
A novel treatment for primary axillary hyperhidrosis in patients ≥9 years.
Green LJ, Hebert AA, Bhatia N, Martin L, Cartwright MM
Journal of the American Academy of DermatologyIn the feed 31 Aug 2026, published online 31 Aug 2026, issue 2026 Aug 31, added to PubMed 31 Aug 2026
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42674074 · DOI 10.1016/j.jaad.2026.08.100